KKD Healthcare Analytics | TalkMarkets | Page 4
Healthcare Expert With 30 Years Experience
Contributor's Links: Dr KKD Healthcare Stock Tips

KKD Healthcare Analytics is a niche healthcare investment advisory service. Our goal is to channel our medical knowledge and long track record as a private investor into a website that will be the ultimate go-to place for knowledge and information about biotech ...more

Articles

Latest Posts
49 to 64 of 67 Posts
MediWound Receives Permission To Expand Study Population Scope
MediWound announced that it has been granted that it has received an endorsement from The European Medicines Agency for expanding the patient population in Phase 3 Children Innovative Debridement Study.
Ophthotech Corp Appoints New CFO And COO
Ophthotech Corp reported it is looking at strategic alternatives for maximizing returns to its shareholders.
Emergent BioSolutions Get Approval For New Construction Site In Germany
Emergent BioSolutions announced receiving approval from German Federal Ministry of Health for the construction of Building 55. The building will be used for manufacturing BioThrax.
Eli Lilly Cancels Long Running Collaboration With Adocia
Eli Lilly and Co announced that it has terminated its collaboration with Adocia.
Endo International Cuts 90 Jobs
Endo International announced restructuring it business as it plans to cut down 90 full-time jobs, in order to cut costs of operations. The step is likely to result in saving of $40 million to $50 million a year.
Cytori Therapeutics Acquires Assets Of Azaya Therapeutics
Cytori Therapeutics announced the acquisition of certain assets from Azaya Therapeutics, which is a privately held firm.
AbbVie Inc. Increases Humira Prices, Receives FDA Approval For New Drug
AbbVie company has announced its decision to hike the price of its Humira drug by over 8%.
A Quick Look At Recro Pharma
Recro Pharma develops non-opioid drugs for pain management. REPH is targeting an NDA this year for its fast-acting IV version of Meloxicam, a well-known NSAID whose oral version just takes too long to work, but has been shown to be effective.
Abbott Laboratories Continues The Launch Of New Products, Stock Rises
Abbott Laboratories announced that it has launched its Proclaim DRG Neurostimulation System in Europe.
Forward Pharma Settles The Case With Biogen
Forward Pharma A/S announced that it has signed a Settlement and License Agreement with Biogen.
Herbalife Starts The Year With Renewed Upswing
Herbalife has been under FTC radar for quite some time. Last year, the company was made to agree to a $200 million settlement with the FTC for compensating its distributors.
TSRO Gains On Agreement With Janssen JNJ
Tesaro shares have risen sharply in early trading today after the company signed a license and collaboration deal with Janssen Biotech.
GILD Strengthens NASH Pipeline
Gilead Sciences is finally making an acquisition.
VRX Seeks Amendment And Waiver To Credit Facility
Valeant Pharmaceuticals International continues to be in news. On Wednesday, the stock dropped more than 6% even as the company announced that it has initiated the process to secure an amendment and waiver to its credit facility.
Premarket Biotech Digest 2016-03-31: VRX Debt, OPK RAYALDEE NDA, ICPT Presentation
Daily premarket biotech digest for March 31, 2016.
Acadia Pharmaceuticals: Nuplazid Gets Overwhelming Backing
Acadia Pharmaceuticals made it. The company’s New Drug Application for Nuplazid was overwhelmingly backed by the advisory panel for approval.
49 to 64 of 67 Posts